The Guardian, Saturday 14 February, 2009 reported that Andrew Witty, the head honcho of GlaxoSmithKline (GSK) strongly believes, “patents are social construct that must rest upon ethical foundation”.Witty with his earlier various ‘out of box’ decisions, appears to gradually establish himself as the pace setter in the new paradigm of the global pharmaceutical industry. The Guardian reports that GSK intends to slash drug prices by 75% or more in the poorest countries of the world. Witty also let the world know that GSK will freely share patent knowledge of the diseases of poor, like malaria, with all concerned.I reckon, Andrew Witty will not only walk the talk, but perhaps will walk even an extra mile to set a new trend within the global pharmaceutical industry, in its pursuit to ensure access to affordable modern medicine, to the ailing population of the world. By Tapan Ray

Disclaimer:Views/opinion expressed in this article are entirely my personal, written on my individual and personal capacity. I do not represent any other person or any organization for this opinion.